VulnerabilityPublished 20 Sep 2026Updated 17 Oct 2026

CVE-2026-94033: SourceCodester Drug Recommendation System · Cross-site Scripting

Affects SourceCodester Drug Recommendation SystemSource CVE Database V5

Compare

Public exploit available · CVSS 5.1 Medium.

Data as of 3 Nov 2026, 10:58 UTC

CVSS 4.0 base score

5.1Medium

How severe the flaw is on the 0–10 CVSS scale.

EPSS: 0.3% chance of exploitation in 30 days – higher than 28% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P

Base metrics

Attack Vector: Network
Attack Complexity: Low
Attack Requirements: None
Privileges Required: Low
User Interaction: Passive
Vulnerable system confidentiality: None
Vulnerable system integrity: Low
Vulnerable system availability: None
Subsequent system confidentiality: None
Subsequent system integrity: None
Subsequent system availability: None

Threat metrics

Exploit Maturity: POC

Bold values are the worst case: easiest to exploit or largest impact.

Attack Vector: Network: The vulnerable system is bound to the network stack and the set of possible attackers extends beyond the other options listed below, up to and including the entire Internet. Such a vulnerability is often termed “remotely exploitable” and can be thought of as an attack being exploitable at the protocol level one or more network hops away (e.g., across one or more routers).
Attack Complexity: Low: The attacker must take no measurable action to exploit the vulnerability. The attack requires no target-specific circumvention to exploit the vulnerability. An attacker can expect repeatable success against the vulnerable system.
Attack Requirements: None: The successful attack does not depend on the deployment and execution conditions of the vulnerable system. The attacker can expect to be able to reach the vulnerability and execute the exploit under all or most instances of the vulnerability.
Privileges Required: Low: The attacker requires privileges that provide basic capabilities that are typically limited to settings and resources owned by a single low-privileged user. Alternatively, an attacker with Low privileges has the ability to access only non-sensitive resources.
User Interaction: Passive: Successful exploitation of this vulnerability requires limited interaction by the targeted user with the vulnerable system and the attacker’s payload. These interactions would be considered involuntary and do not require that the user actively subvert protections built into the vulnerable system.
Vulnerable system confidentiality: None: There is no loss of confidentiality within the Vulnerable System.
Vulnerable system integrity: Low: Modification of data is possible, but the attacker does not have control over the consequence of a modification, or the amount of modification is limited. The data modification does not have a direct, serious impact to the Vulnerable System.
Vulnerable system availability: None: There is no impact to availability within the Vulnerable System.
Subsequent system confidentiality: None: There is no loss of confidentiality within the Subsequent System or all confidentiality impact is constrained to the Vulnerable System.
Subsequent system integrity: None: There is no loss of integrity within the Subsequent System or all integrity impact is constrained to the Vulnerable System.
Subsequent system availability: None: There is no impact to availability within the Subsequent System or all availability impact is constrained to the Vulnerable System.
Exploit Maturity: POC: Based on threat intelligence sources each of the following must apply: · Proof-of-concept is publicly available · No knowledge of reported attempts to exploit this vulnerability · No knowledge of publicly available solutions used to simplify attempts to exploit the vulnerability

Definitions: FIRST CVSS v4.0 specification.

Exploitation evidence

Disclosed: evidence found.
CVE published 20 Sep 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: evidence found.
CVSS exploit maturity: proof of concept public
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), CVSS vector, the Metasploit, Exploit-DB and nuclei-templates index as of 3 Nov 2026.

Disclosed: The CVE record is public on cve.org. Its publication is t = 0.
Detectable: A public nuclei template can find exposed instances, for defenders and attackers alike.
Weaponized: A Metasploit exploit module or Exploit-DB entry exists (Metasploit scanner modules do not count), or CISA SSVC or the CVSS exploit maturity reports a public proof of concept.
Exploited in the wild: CISA KEV lists it, CISA SSVC rates exploitation active, or a source reports attacks.
Observed by OffSeq Mirage: OffSeq Mirage honeypot sensors recorded attack traffic for this CVE, or found exposed hosts without attack traffic.

Moments are spaced evenly, not to scale; a dashed line marks a gap of six months or more. Deltas count from t = 0. Sources that give only a date (CISA KEV, Exploit-DB, or a time of exactly 00:00Z) read “same day” rather than hours. Metasploit modules carry the flaw’s disclosure date, not their release date, and nuclei templates carry no date, so both appear above but not on the timeline.

What to do

Affected software

Product	Affected	Fixed in
SourceCodesterDrug Recommendation System	Affected =1.0	Fixed in–
GitHubkaranparelkar/Drug_recommendation_system`pkg:github/karanparelkar/Drug_recommendation_system`Other threats	Affected =1.0	Fixed in–

CPE configurations (1)

cpe:2.3:a:sourcecodester:drug_recommendation_system:*:*:*:*:*:*:*:*

Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.

AI-suggested

Until an official fix is available, users should apply web application firewall rules to detect and block XSS payloads targeting the affected parameters and consider disabling or restricting access to the vulnerable add_user functionality if feasible.

Description

CVE-2026-94033 is a cross-site scripting (XSS) vulnerability in SourceCodester Drug Recommendation System version 1.0. It affects the User Management component, specifically the /drug_recommender/Admin/add_user file. The vulnerability arises from improper handling of input parameters txtname, txtemail, and txtpassword, allowing remote attackers to inject malicious scripts. The vulnerability has a medium severity score and public exploit details have been disclosed.

Impact

Successful exploitation could allow an attacker to execute arbitrary scripts in the context of the affected web application, potentially leading to session hijacking, defacement, or other client-side attacks. The vulnerability requires user interaction and low privileges to exploit. There is no indication of direct server compromise or data breach from the provided data.

Summary

This vulnerability in SourceCodester Drug Recommendation System 1.0 allows remote attackers to perform cross-site scripting attacks by manipulating the txtname, txtemail, or txtpassword parameters in the /drug_recommender/Admin/add_user component. The flaw is due to insufficient input sanitization, enabling injection of malicious scripts that can execute in the context of the victim's browser. The CVSS 4.0 score is 5.1 (medium), indicating moderate impact with low attack complexity and no privileges required but user interaction needed.

References

Community reviews

Loading reviews…